CRT 2024

REDEFINING PERI PROCEDURAL MI IN CLINICAL TRIALS

Moderator(s)

• 

  Donald E. Cutlip, MD, FACC

  Vice Chair, Department of Medicine
  Beth Israel Deaconess Medical Center
  Boston, Massachusetts, United States

  Disclosure information not submitted.
• 

  P F Adrian Magee, MD

  Physician/Medical Officer (Cardiology)
  FDA
  Silver Spring, Maryland, United States

  No relationships to disclose
• 

  Ernest Spitzer, MD

  Chief Executive Officer
  Cardialysis B.V.
  Rotterdam, Zuid-Holland, Netherlands

  No relationships to disclose